Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayesh Desai

Showing results (51-60 of 179) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2011
Clinical, pharmacodynamic, and pharmacokinetic evaluation of BNC105P: a phase I trial of a novel vascular disrupting agent and inhibitor of cancer cell proliferationDanny Rischin, David C Bibby, Geoff Chong, et al.
Cancer|April 2, 2011
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancerBen Tran, Scott Kopetz, Jeanne Tie, et al.
Biotechnology Progress|June 24, 2021
Determination of protein concentration in downstream biomanufacturing processes by in-line index of refractionSteven A Harris, Bhumit A Patel, Adrian Gospodarek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitorsChandrajit P Raut, Matthew Posner, Jayesh Desai, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|March 25, 2024
Clinical activity in general practice before sarcoma diagnosis: an Australian cohort studyMeena Rafiq, Jasper de Boer, Jasmine Mar, et al.
Asia-Pacific Journal of Clinical Oncology|August 19, 2014
Translation of clinical trial outcomes to metastatic colorectal cancer patients in community practiceSheau Wen Lok, Hui-Li Wong, Suzanne Kosmider, et al.
NPJ Precision Oncology|January 13, 2026
Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trialTing Pu, Allyson M Peddle, Pratyaksha Wirapati, et al.
NPJ Precision Oncology|June 24, 2021
Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncologyFrank P Lin, Subotheni Thavaneswaran, John P Grady, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2023
Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapiesAdel Shahnam, Nadia Hitchen, Udit Nindra, et al.
Cancer|March 27, 2007
Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: results of a phase II trialPalma Dileo, Jeffrey A Morgan, David Zahrieh, et al.
Pageof 18

Showing results (51-60 of 179) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2011
Clinical, pharmacodynamic, and pharmacokinetic evaluation of BNC105P: a phase I trial of a novel vascular disrupting agent and inhibitor of cancer cell proliferationDanny Rischin, David C Bibby, Geoff Chong, et al.
Cancer|April 2, 2011
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancerBen Tran, Scott Kopetz, Jeanne Tie, et al.
Biotechnology Progress|June 24, 2021
Determination of protein concentration in downstream biomanufacturing processes by in-line index of refractionSteven A Harris, Bhumit A Patel, Adrian Gospodarek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitorsChandrajit P Raut, Matthew Posner, Jayesh Desai, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|March 25, 2024
Clinical activity in general practice before sarcoma diagnosis: an Australian cohort studyMeena Rafiq, Jasper de Boer, Jasmine Mar, et al.
Asia-Pacific Journal of Clinical Oncology|August 19, 2014
Translation of clinical trial outcomes to metastatic colorectal cancer patients in community practiceSheau Wen Lok, Hui-Li Wong, Suzanne Kosmider, et al.
NPJ Precision Oncology|January 13, 2026
Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trialTing Pu, Allyson M Peddle, Pratyaksha Wirapati, et al.
NPJ Precision Oncology|June 24, 2021
Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncologyFrank P Lin, Subotheni Thavaneswaran, John P Grady, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2023
Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapiesAdel Shahnam, Nadia Hitchen, Udit Nindra, et al.
Cancer|March 27, 2007
Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: results of a phase II trialPalma Dileo, Jeffrey A Morgan, David Zahrieh, et al.
Pageof 18